The Column Group II, LP 13D and 13G filings for RAPT Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-12-23 8:20 pm Sale |
2024-12-23 | 13D | RAPT Therapeutics, Inc. RAPT |
The Column Group II, LP | 1,603,593 4.900% |
-2,821,846 (-63.76%) |
Filing |
| 2023-01-13 4:50 pm Purchase |
2022-05-10 | 13D | RAPT Therapeutics, Inc. RAPT |
The Column Group II, LP | 4,425,439 13.100% |
1,269,211 (+40.21%) |
Filing |
| 2021-09-20 5:18 pm Sale |
2021-09-10 | 13D | RAPT Therapeutics, Inc. RAPT |
The Column Group II, LP | 3,156,228 10.700% |
-1,201,019 (-27.56%) |
Filing |
| 2021-08-30 5:21 pm Sale |
2021-08-18 | 13D | RAPT Therapeutics, Inc. RAPT |
The Column Group II, LP | 4,357,247 14.800% |
-1,295,750 (-22.92%) |
Filing |
| 2020-10-01 4:15 pm Sale |
2020-09-22 | 13D | RAPT Therapeutics, Inc. RAPT |
The Column Group II, LP | 5,652,997 23.100% |
-608,000 (-9.71%) |
Filing |
| 2020-08-26 4:42 pm Sale |
2020-08-17 | 13D | RAPT Therapeutics, Inc. RAPT |
The Column Group II, LP | 6,260,997 25.600% |
-516,154 (-7.62%) |
Filing |